Financial statements Pluspharma

Balance sheet of Pluspharma

Company age:
Age:
11 y. 8 m. 18 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of PLUSPHARMA

Year
2018
2019
2020
2021
2022
2023
Total assets 16 065 887,85 14 081 372,57 15 298 955,30 13 851 006,94 15 864 654,08 16 472 089,16
A. Fixed assets 6 795 912,26 5 307 971,87 4 967 143,10 4 372 948,41 4 587 865,55 3 215 306,62
B. Current assets 9 269 975,59 8 773 400,70 10 331 812,20 9 478 058,53 11 276 788,53 13 256 782,54
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 16 065 887,85 14 081 372,57 15 298 955,30 13 851 006,94 15 864 654,08 16 472 089,16
A. Equity -16 788 364,53 -17 975 893,41 -19 086 426,91 -17 463 312,67 -15 488 046,60 -17 473 881,75
B. Liabilities and provisions for liabilities 32 854 252,38 32 057 265,98 34 385 382,21 31 314 319,61 31 352 700,68 33 945 970,91
I. Long-term liabilities - - - - - -
II. Short-term liabilities 31 198 674,56 30 778 627,62 32 322 734,46 30 267 734,26 29 846 009,64 32 125 842,72
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.